{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-005581","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.942140+00:00","generated_at":"2026-06-06T21:09:32.060295+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Precision BioSciences stockholders approve reverse split; board authorized to set ratio 1-for-10 to 1-for-30","bullets":["Approximately 68.34% of common shares represented at special meeting on January 18, 2024.","Proposal 1 passed: 71,771,593 votes for (86.1%), 11,275,251 against, 281,803 abstain.","Board has discretion to fix the reverse split ratio between 1-for-10 and 1-for-30 and may abandon the amendment.","Adjournment proposal also passed (75.3M for) but was not needed as Proposal 1 received sufficient votes."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-005581","json":"https://secwatch.observer/filing/0000950170-24-005581.json","markdown":"https://secwatch.observer/filing/0000950170-24-005581.md","text":"https://secwatch.observer/filing/0000950170-24-005581.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024005581/0000950170-24-005581-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024005581/dtil-20240118.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:09:32.060295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4cffb451a788c5dfc4ec80d7b56010dcb0a31844","claim":"PRECISION BIOSCIENCES INC shareholders approved Approval of amendments to the company's amended and restated certificate of incorporation to effect a reverse stock split of the company's common stock at a ratio ranging from 1-for-10 to 1-for-30 at the 2024-01-18 meeting.","evidence_excerpt":"Proposal 1 – The approval of amendments to the Company’s amended and restated certificate of incorporation to effect a reverse stock split of the Company’s Common Stock at a ratio ranging from any whole number between 1-for-10 and 1-for-30, as determined by the Company’s Board of Directors (the “Board”) in its discretion, subject to the Board’s authority to abandon such amendments. Votes FOR Votes AGAINST Votes ABSTAINED BROKER NON-VOTES 71,771,593 11,275,251 281,803 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024005581/0000950170-24-005581-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-18"}],"fact_type":"shareholder_vote"},{"claim_id":"ae8103b9f4177c91dc648b48dc6476b2e2f095a8","claim":"PRECISION BIOSCIENCES INC shareholders approved Approval of an adjournment of the Special Meeting, if necessary, to solicit additional proxies at the 2024-01-18 meeting.","evidence_excerpt":"Proposal 2 – The approval of an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve Proposal 1. Votes FOR Votes AGAINST Votes ABSTAINED BROKER NON-VOTES 75,291,080 7,698,338 339,229 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024005581/0000950170-24-005581-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-18"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}